AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

589.471

+16.8152.94%

Number of Gainers:23

Number of Losers:5

Number of Flat:17

PE:- -

High:592.584

Open:578.610

Low:575.087

Close:572.657

Volume:39.64M

Turnover:157.69M

Market Cap:81.09B

Float Cap:78.18B

Loading ...

Monero price flips daily structure bullish, $473 target emerges

Emerging Growth Research reiterates Buy-Extended on Immuron with $3.90 price target

CSL - Seqirus Will Provide Adjuvanted Cell-Based Vaccines to Support Canada IF Influenza Pandemic Is Declared by the World Health Organization

THOMSON REUTERS

CSL - CSL Seqirus Awarded New Contract to Support Influenza Pandemic Preparedness Plans of Canadian Government’s Public Health Agency of Canada

THOMSON REUTERS

Vermiculus delivers VeriClear-based risk systems to OCC

Immuron CEO Steven Lydeamore to Present Virtually at Coffee Microcaps Conference

Clinuvel Pharmaceuticals announces investor webinar release for the six months ended 31 December 2025

Market Chatter: CSL Secures Canada Pandemic Influenza Vaccine Supply Contract, AFR Says

MT Newswires Live

Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading

MT Newswires Live

Skillful Craftsman Unit Signs 12-Month CSL AI Service Deal With China Auto Insurance Firm

Neuren's Royalties From Daybue Sales Beat Bull's Forecast -- Market Talk

Arcturus Therapeutics Q4 net loss narrows

Analog Devices Inc Stock Opened Down by 3.38% on Mar 3: Key Drivers Unveiled

Arista Networks Inc Stock Opened Down by 3.07% on Mar 3: A Full Analysis

PAR Technology Launches Artificial Intelligence Suite for Convenience Retailers

MT Newswires Live

Pfisterer posts FY 2025 order backlog of EUR 335 million, up more than 40%

BUZZ-Australia's Neuren Pharmaceuticals drops as US partner seeks EMA re-examination

Neuren Partner Plans to Request Re-examination of European Authority's Opinion on Trofinetide Marketing Authorization Application

MT Newswires Live

Immuron HY26 net loss narrows 22.9% to AUD 1.9 million

Indonesia's Soekarno-Hatta Reschedules 39 Middle East Flights

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7508/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":589.4711,"timestamp":1772686799960,"preClose":572.65656,"halted":0,"volume":39636658,"delay":0,"changeRate":0.029362,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":16.814575,"latestTime":"03-05 16:00:00 AEDT","open":578.61017,"high":592.5843,"low":575.08746,"amount":157693091,"amplitude":0.030554,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772751600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1772665200000,1772686800000]],"turnoverRate":0.001523,"increases":24,"decrements":5,"flats":14,"marketCap":81088274010,"floatMarketCap":78177913407.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":592.5843,"amplitude":0.030554,"preClose":572.65656,"low":575.08746,"latestPrice":589.4711,"volume":39636658,"delay":0,"open":578.61017,"prevYearClose":644.3692,"prevWeekClose":592.49,"prevMonthClose":592.49,"prevQuarterClose":644.369,"fiveDayClose":592.019,"twentyDayClose":676.407,"sixtyDayClose":672.551,"secType":"PLATE","market":"AU","turnoverRate":0.001523,"marketCap":81088274010,"floatMarketCap":78177913407.75,"timestamp":1772686799960,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":23,"down":5,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617578255","title":"Monero price flips daily structure bullish, $473 target emerges","url":"https://stock-news.laohu8.com/highlight/detail?id=2617578255","media":"cryptonews","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617578255?lang=en_us&edition=fundamental","pubTime":"2026-03-06 03:20","pubTimestamp":1772738431,"startTime":"0","endTime":"0","summary":"Monero price has confirmed a bullish market structure shift on the daily timeframe after reclaiming key support. If the $357 level continues to hold, the next major upside target sits at the $473 resistance.Bullish structure confirmed:Monero printed a higher low followed by a new higher high on the daily chart.$357 flipped to support:Former resistance now acting as key support for continuation.$473 target:Next major high-timeframe resistance if bullish momentum holds.Monero  price is beginning to show renewed bullish momentum after a decisive structural shift on the daily chart. The recent price action suggests that buyers have regained control of the market following a confirmed break in market structure.Such structural confirmations often precede strong directional moves as market participants reposition in line with the new trend. In the broader market narrative, several leading cryptocurrencies attracting trader attention include BCH, XMR, HYPE, and BlockDAG, as investors continue ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/monero-price-flips-daily-structure-473-target-emerges/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/monero-price-flips-daily-structure-473-target-emerges/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["MSB.AU","MSB","BK4006","BK7067","BK7508","BK7501"],"gpt_icon":0},{"id":"2617521692","title":"Emerging Growth Research reiterates Buy-Extended on Immuron with $3.90 price target","url":"https://stock-news.laohu8.com/highlight/detail?id=2617521692","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617521692?lang=en_us&edition=fundamental","pubTime":"2026-03-06 00:05","pubTimestamp":1772726729,"startTime":"0","endTime":"0","summary":"Emerging Growth Research reiterates Buy-Extended on Immuron with $3.90 price target               Emerging Growth Research issued a Flash Research Update on Immuron Limited (Nasdaq: IMRN), maintaining","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL8pcqPz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2617648547","title":"CSL - Seqirus Will Provide Adjuvanted Cell-Based Vaccines to Support Canada IF Influenza Pandemic Is Declared by the World Health Organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2617648547","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617648547?lang=en_us&edition=fundamental","pubTime":"2026-03-05 21:01","pubTimestamp":1772715701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT0SK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","CSL.AU","BK7501","BK7511"],"gpt_icon":0},{"id":"2617547577","title":"CSL - CSL Seqirus Awarded New Contract to Support Influenza Pandemic Preparedness Plans of Canadian Government’s Public Health Agency of Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2617547577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617547577?lang=en_us&edition=fundamental","pubTime":"2026-03-05 21:01","pubTimestamp":1772715701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT0SK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CSL.AU","BK7511","BK7067","BK7501"],"gpt_icon":0},{"id":"2617994546","title":"Vermiculus delivers VeriClear-based risk systems to OCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2617994546","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617994546?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:10","pubTimestamp":1772709000,"startTime":"0","endTime":"0","summary":"The Options Clearing Corporation  has accepted delivery of two essential microservice-based risk systems from Vermiculus within a few months of implementation.STOCKHOLM, March 5, 2026 /PRNewswire/ -- Vermiculus, global provider of clearing, trading and CSD technology, has delivered two VeriClear-based and modular risk systems to The Options Clearing Corporation, the world's largest equity derivatives clearing organization.\"With scalable, cloud-native microservice architecture and real-time data capabilities, the new risk systems will play a central role in OCC's risk management. Our close collaboration with Vermiculus, has been key in developing our capabilities,\"says John Martino, Managing Director, Clearing Systems at OCC. \"Vermiculus' level of quality and reliable delivery are highly valued,\" adds Martino.\"OCC is one of Vermiculus' first customers, and we have worked closely with them throughout their ongoing technology transformation. This transparent and collaborative partnership ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/vermiculus-delivers-vericlear-based-risk-systems-to-occ-302705229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","SEC.AU","BK7508","BK4020","OCC","CCP.AU","OCC.AU","BK7093"],"gpt_icon":0},{"id":"2617454695","title":"Immuron CEO Steven Lydeamore to Present Virtually at Coffee Microcaps Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2617454695","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617454695?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:00","pubTimestamp":1772708458,"startTime":"0","endTime":"0","summary":"Immuron CEO Steven Lydeamore to Present Virtually at Coffee Microcaps Conference               Immuron Limited said CEO Steven Lydeamore will present virtually at the Coffee Microcaps Conference on Th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL1v9Hbp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IMC.AU","SG9999014005.SGD","BK4588","SG9999014021.USD","LU2210149790.SGD","NDAQ","SG9999014013.SGD","SG9999014039.USD","LU2095319765.USD","IE00BGHQF748.EUR","BK7508","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","LU2210150020.SGD","BK7067","LU0314104364.USD"],"gpt_icon":0},{"id":"2617599594","title":"Clinuvel Pharmaceuticals announces investor webinar release for the six months ended 31 December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2617599594","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617599594?lang=en_us&edition=fundamental","pubTime":"2026-03-05 10:48","pubTimestamp":1772678913,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals Limited announced the availability of an investor and analyst webinar  discussing its financial results for the six months ended 31 December 2025, hosted at 18:00 AEDT on 26 February 2026, posted at CLINUVEL news website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clinuvel Pharmaceuticals Limited published the original content used to generate this news brief on March 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL7ks45p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","CUV.AU"],"gpt_icon":0},{"id":"2617811596","title":"Market Chatter: CSL Secures Canada Pandemic Influenza Vaccine Supply Contract, AFR Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2617811596","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617811596?lang=en_us&edition=fundamental","pubTime":"2026-03-05 10:26","pubTimestamp":1772677570,"startTime":"0","endTime":"0","summary":"CSL's  influenza vaccine unit, Seqirus, has secured a contract to supply 15 million doses of a cell-based adjuvanted pandemic flu vaccine from its new Melbourne facility if a pandemic is declared by the World Health Organization, according to a Thursday report by the Australian Financial Review.CSL Seqirus has previously had a contract with Canada, under which it was required to provide an egg-based influenza vaccine in the event of a pandemic, the report added.The company's shares rose almost 2% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGXZ23171101.USD","BK7067","LU1169590202.USD","BK4086","BK7508","LU0728928796.USD","LU1169589451.USD","BK7501","SG9999004303.SGD","BK7511","CSL.AU","CSL"],"gpt_icon":0},{"id":"2616551077","title":"Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2616551077","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616551077?lang=en_us&edition=fundamental","pubTime":"2026-03-04 23:38","pubTimestamp":1772638709,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were modestly higher Wednesday morning, rising 0.30% to 2,790.11 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by consumer lended Eason Technology  and computer hardware maker Canaan , which climbed 19% and 9%, respectively. They were followed by diagnostic imaging centers company Concord Medical Services  and biopharmaceutical firm Zai Lab , which advanced 7.3% and 6.4%, respectively.The decliners from North Asia were led by thin-film liquid display maker LG Display  and fintech firm AMTD Digital , which dropped 9% and 4.9% respectively. They were followed by lender CNFinance  and automotive marketplace Cango , which lost 3% and 1.8% respectively.From South Asia, the gainers were led by IT firms Sify Technologies  and Infosys , which rose 4.3% and 1.6% respectively. They were followed by pharmaceutical company Dr. Reddy's Laboratories  and tech conglomerate Sea , which were up 0.7% and 0.6% respective","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861220207.SGD","BK7095","BK4523","LU0979878070.USD","LU0143863198.USD","LU0868486357.SGD","LU1323998911.USD","LU0791590937.USD","LU0516422366.SGD","CAN","LU0823039010.USD","BK4139","LU0289960550.SGD","LU0516422440.USD","HKD","BK7508","LU0541501648.USD","BK4132","LU2045819591.USD","LU1805238398.USD","BK4526","LU0251143029.SGD","BK4122","IE00B3M56506.USD","LU0589944569.HKD","LU0572939691.SGD","BK4535","SG9999013478.USD","BK4220","LU0821914370.USD","LU2065171311.SGD","LU0348788117.USD","BK4134","SG9999004220.SGD","LU2087589342.USD","BK4595","BK7096","BK4518","BK4207","LU0066902890.USD","LU0210637038.USD","IE0001KFT4U8.USD","BK4503","IE0034224299.USD","LU2125910849.SGD","BK4581","LU0231203729.USD","LU2065170008.USD","LU0862451753.SGD","LU0898667661.SGD","TLK","LU1839390173.USD","BK4115","BK4214","LU0264410563.USD","LU1242518931.SGD","LU1366334578.USD","LU0541502299.USD","PHI","LU1868837565.USD","BK4533","LU0572940350.SGD","LU0791591158.USD","SG9999014484.SGD","LU0345776255.USD","RDY","LU0264606111.USD","LU0251143458.SGD","LU1861217088.USD","LU0143863784.USD","SG9999013460.SGD","LU0164881194.USD","BK4196","BK4085","WIT","LU1508157978.USD","LU2152927971.USD","IE00BYTNYM70.SGD","LU0175139822.USD","09688","BK4170","BK4588","BK7016","LU0708995666.HKD","LU1804176565.USD","LU1102505929.USD","LU1481012133.USD","LU2543165471.USD","IE00BD6J9T35.USD","BK4164","BK4532","CNF","LU2125910500.SGD","BK4148","LU0499858438.USD","LU2065169927.USD","BK4117","LU2265009873.SGD","BK4548","LU0531971678.HKD","LU0828237940.HKD","SG9999002414.USD","LU0441851309.USD","LU0072462343.USD","LU0307460401.USD","LU0516422952.EUR","LU1048596156.SGD","LU2238330802.EUR","INFY","BK4596","LU0737861269.HKD","LU0048575426.USD","LU0248272758.USD","BK4585","SG9999001135.SGD","LU1242518857.USD","LU2488822045.USD","SG9999002406.SGD","IE0031814969.USD","SG9999002620.SGD","LU1868837722.USD","BK4195","LU0532188223.SGD","BK4600","LU1366334651.USD","LU2008162690.USD","LU0536402901.SGD","LU1868838027.USD","SG9999004360.SGD","LU0516423091.SGD","LU1048588211.SGD","IE00B7N09G41.SGD","CCM","ZLAB","LU0197229882.USD","BK4229","BK4023","SG9999014492.USD","LU0345775950.USD","LU2663582299.SGD","SIFY","CANG","LU0823038988.USD","BK4107","BK4531","SG9999005177.SGD","LU0431992006.USD","BK4557","SG9999006266.SGD","LU0499858602.USD","LU0261945553.USD","BK4007","LU0333810181.USD","BK7502","SGXZ58947870.SGD","SG9999002679.SGD","IBN","LU0287143357.SGD","LU0890818403.SGD","BK4554","LU0261950470.USD","LU1267930656.SGD","DXF","LU2065171402.SGD","LU0831103253.SGD","LU2177674079.SGD","LU0048573645.USD","SG9999002604.SGD","SG9999013486.USD","BK4566","LU0348744763.USD","BK4089","BK4551","LU1770036033.HKD","LU0181495838.USD","LU2360107671.USD","LU0516423174.USD","IE00B0JY6M65.USD","LU1102505762.USD","LPL"],"gpt_icon":1},{"id":"2616553266","title":"Skillful Craftsman Unit Signs 12-Month CSL AI Service Deal With China Auto Insurance Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2616553266","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616553266?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:31","pubTimestamp":1772631080,"startTime":"0","endTime":"0","summary":"Skillful Craftsman Education Technology Ltd. said its wholly owned subsidiary, Shenzhen Qianhai Jisen Information Technology Co., Ltd., signed an AI Technology Service and Product Sales Agreement with an auto insurance service company in China. Under the 12-month contract, Jisen will provide its self-developed Communication Skills Learning  intelligent communication assistance product and related services for employee training, customer service support, and sales script optimization. The agreement runs from Feb. 25, 2026 to Feb. 24, 2027, with monthly fees of RMB 100,000 excluding tax.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL6hnCqS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","EDTK","BK4585","BK7511","CSL.AU","BK4588","NDAQ","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","LU2210150020.SGD","BK7501","SG9999014005.SGD","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","BK4204","SG9999014021.USD","SG9999014013.SGD","SG9999014039.USD","BK7508","IE00B64PRP62.GBP","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2616137072","title":"Neuren's Royalties From Daybue Sales Beat Bull's Forecast -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616137072","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616137072?lang=en_us&edition=fundamental","pubTime":"2026-03-04 07:08","pubTimestamp":1772579280,"startTime":"0","endTime":"0","summary":"2308 ET - Royalty revenue flowing to Neuren Pharmaceuticals from U.S. sales of the Daybue treatment for Rett Syndrome last year beat Macquarie's expectations. Acadia Pharmaceuticals, Neuren's partner, said U.S. net sales of Daybue totaled US$391 million in 2025. That was above the US$350 million of sales achieved in 2024. Macquarie says the sales outcome translates to A$65.0 million in royalties for Neuren, up 15% on year. This is 1.5% higher than its forecast of A$64.0 million. \"Royalty revenue ahead of expectations, driven by growth in new patient prescriptions,\" Macquarie says. \"Neuren's strong cash position enables pipeline acceleration, potentially providing significant long-term upside.\" It has an outperform call on Neuren. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","NEU.AU","BK7096"],"gpt_icon":0},{"id":"2616737103","title":"Arcturus Therapeutics Q4 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2616737103","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616737103?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:09","pubTimestamp":1772572187,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Q4 net loss narrowsOverviewmRNA medicines firm's Q4 revenue fell due to reduced CSL collaboration activityOperating expenses for Q4 decreased, driven by lower manufacturing and c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL1N3ZR192:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","CSL.AU","BK7501","BK7511","ARCT","BK4139"],"gpt_icon":0},{"id":"2616432169","title":"Analog Devices Inc Stock Opened Down by 3.38% on Mar 3: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2616432169","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616432169?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:47","pubTimestamp":1772549262,"startTime":"0","endTime":"0","summary":"• Stock trading ex-dividend on March 3, 2026, causes price adjustment.\n• CFO appearance at conference may influence trading activity and sentiment.\n• Strong Q1 results and dividend increase contrast with valuation concerns.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/stocks/261640164-market-movers-adi-20260303","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1978683503.SGD","LU0444971666.USD","LU2237443549.SGD","IE00BD6J9T35.USD","ADI","LU2298322129.HKD","IE00BZ199S13.USD","LU2275660780.HKD","LU2458330169.SGD","LU0124384867.USD","LU0077335932.USD","LU1861214812.USD","LU1670711040.USD","LU1803068979.SGD","IE0009356076.USD","ROE","LU1244550494.USD","BK4585","LU2237443978.SGD","LU0724618433.USD","LU0302445910.USD","LU2237438978.USD","LU1861219969.SGD","MOBX","BK4141","BK4605","LU2272731782.SGD","LU2458330243.SGD","BK7508","LU0109392836.USD","LU1670711123.USD","LU0312595415.SGD","OCC.AU","OCC","BK4515","LU0957808578.USD","LU1074936037.SGD","ADI.AU","SELX","BK7067","BK4561","BK4020","LU1244550577.SGD","LU1815336760.USD","LU1992135399.USD","LU2360107325.USD","LU0314104364.USD","LU1670710661.SGD","BK4588","LU1992135472.HKD"],"gpt_icon":0},{"id":"2616532165","title":"Arista Networks Inc Stock Opened Down by 3.07% on Mar 3: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532165","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616532165?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:47","pubTimestamp":1772549250,"startTime":"0","endTime":"0","summary":"• Arista Networks' share price declined due to profit-taking and valuation concerns.\n• Insider selling and NVIDIA's competition are impacting investor confidence.\n• Customer concentration and reduced institutional stakes add to selling pressure.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/stocks/261640163-market-movers-anet-20260303","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1803068979.SGD","BK7067","LU0006306889.USD","LU2355687059.USD","LU2458330243.SGD","LU0353189680.USD","LU0077335932.USD","LU2211815571.USD","OCC.AU","BK7508","IE00BMPRXQ63.HKD","MOBX","BK4141","SG9999001424.SGD","BK4588","LU2286300806.USD","OCC","SELX","IE00BMPRXN33.USD","ANET","BK4543","LU0106261372.USD","LU0353189763.USD","LU0109392836.USD","LU2458330169.SGD","LU0889565833.HKD","IE00BN0W2W23.USD","LU0348723411.USD","LU0557290698.USD","BK4539","LU1917777945.USD","IE00BN0W2T93.GBP","LU2054465674.USD","LU2023250504.SGD","BK4554","IE00BN0W2V16.EUR","LU1974910355.USD","IE00BMPRXR70.SGD","BK4020","LU2087625088.SGD","LU0225283273.USD","LU2106854487.HKD","LU0198837287.USD","LU2108987350.USD","BK4585","IE0008368304.USD"],"gpt_icon":0},{"id":"2616286483","title":"PAR Technology Launches Artificial Intelligence Suite for Convenience Retailers","url":"https://stock-news.laohu8.com/highlight/detail?id=2616286483","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616286483?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:10","pubTimestamp":1772543448,"startTime":"0","endTime":"0","summary":"PAR Technology  said Tuesday it has launched an artificial intelligence-powered product suite designed to provide real-time data insights and automate operations for convenience and fuel retailers.The new platform integrates directly into PAR's existing systems to reduce manual effort and eliminate the need for third-party applications, the company said.The software features modules that allow operators to generate data charts through a chat interface, automatically build promotional campaigns, and develop strategic plans using historical performance and external weather data, PAR said.Shares of the company were down 1.7% in recent Tuesday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","PAR.AU","BK4157","BK4023","BK7067","PAR"],"gpt_icon":0},{"id":"2616316503","title":"Pfisterer posts FY 2025 order backlog of EUR 335 million, up more than 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616316503","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616316503?lang=en_us&edition=fundamental","pubTime":"2026-03-03 15:01","pubTimestamp":1772521268,"startTime":"0","endTime":"0","summary":"PFISTERER posted preliminary unaudited FY 2025 results showing sales of about EUR 450 million  and adjusted EBITDA of about EUR 80 million . Order intake rose to just under EUR 550 million , lifting the order backlog to nearly EUR 335 million  as of Dec. 31, 2025. Adjusted operating cash flow increased to about EUR 58 million , while investments rose to more than EUR 38 million, primarily to expand capacities, build an HVDC laboratory and complete the acquisition of Power CSL. Q4 2025 sales were about EUR 120 million . The company said final audited FY 2025 figures and a 2026 outlook are due on April 15, 2026, and reiterated its strategic focus on capacity expansion, global presence and HVDC-related innovation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL5QCLn2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7501","CSL.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2616925273","title":"BUZZ-Australia's Neuren Pharmaceuticals drops as US partner seeks EMA re-examination","url":"https://stock-news.laohu8.com/highlight/detail?id=2616925273","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616925273?lang=en_us&edition=fundamental","pubTime":"2026-03-03 11:53","pubTimestamp":1772510032,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Neuren Pharmaceuticals drops as US partner seeks EMA re-examination** Shares of Neuren Pharmaceuticals NEU.AX fall 8% to A$12.67, on track for their weakest session since February 5** The biopharma firm says its partner, Acadia Pharmaceuticals ACAD.O, confirms plan to request re-examination of opinion adopted by Committee for Medicinal Products for Human Use of the European Medicines Agency ** Re-examination regarding the marketing of trofinetide for the treatment of Rett syndrome in patients two years and older - co** Australian healthcare stocks .AXHJ down 1.5%, in line with broader benchmark .AXJO which is down 1.2%** YTD, stock down 31.9%, including the day's move  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL4N3ZR0BD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACAD","LU2065170008.USD","BK4139","BK7508","LU2065171402.SGD","LU2065171311.SGD","BK7096","LU2065169927.USD","NEU.AU"],"gpt_icon":0},{"id":"2616609843","title":"Neuren Partner Plans to Request Re-examination of European Authority's Opinion on Trofinetide Marketing Authorization Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2616609843","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616609843?lang=en_us&edition=fundamental","pubTime":"2026-03-03 07:36","pubTimestamp":1772494615,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  said its partner, Acadia Pharmaceuticals, confirmed that it plans to request a re-examination of the European Medicines Agency's Committee for Medicinal Products for Human Use's opinion regarding the marketing authorization application for trofinetide for the treatment of Rett syndrome in patients aged two years and older, according to a Tuesday Australian bourse filing.The committee issued a refusal, saying that the treatment effect observed with trofinetide after 12 weeks, while measurable, was viewed as limited in magnitude, that the Lavender clinical trial did not capture all core symptoms of Rett syndrome, and that the assessment of longerterm outcomes was influenced by patient discontinuations over time.Trofinetide is approved in the US, Canada, and Israel, per the filing.Neuren Pharmaceuticals' shares fell 5% in early trading on Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","NEU.AU","BK7096"],"gpt_icon":0},{"id":"2616333591","title":"Immuron HY26 net loss narrows 22.9% to AUD 1.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616333591","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616333591?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:10","pubTimestamp":1772449801,"startTime":"0","endTime":"0","summary":"Immuron reported HY26 revenue from ordinary activities of AUD 4.2 million, up 4.8%, and a loss after tax attributable to shareholders of AUD 1.9 million, down 22.9%, for the six months ended 31 December 2025. Net tangible assets were 3.94 cents per share at 31 December 2025. The company ended the half with cash and cash equivalents of AUD 10.0 million and net assets of AUD 13.1 million. Operationally, Immuron highlighted record HY26 sales of AUD 4.2 million , including Travelan sales growth in Australia to AUD 3.2 million  and in the US to AUD 0.9 million , while Canada Travelan sales declined to AUD 0.1 million. Key updates included FDA approval of the IMM-529 investigational new drug application for a Phase 2 trial in Clostridioides difficile infection, a new US Department of Defense award to develop oral therapeutics targeting Campylobacter and Shigella, release of topline data from a Uniformed Services University trial of a third-party manufactured IMM-124E product, and the launch ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLbT1rRh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMC.AU"],"gpt_icon":0},{"id":"2616038420","title":"Indonesia's Soekarno-Hatta Reschedules 39 Middle East Flights","url":"https://stock-news.laohu8.com/highlight/detail?id=2616038420","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616038420?lang=en_us&edition=fundamental","pubTime":"2026-03-02 16:10","pubTimestamp":1772439012,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-The Soekarno-Hatta International Airport  Branch Office of PT Angkasa Pura Indonesia  in Tangerang, Banten, adjusted the departure schedules of 39 flights to the Middle East that had been postponed due to the conflict in the region.Aziz Fahmi Harahap, the Acting Assistant Deputy for Communication and Legal Affairs at Soekarno-Hatta International Airport, said on Monday in Tangerang that, as of 10:00 AM local time, there were 39 scheduled flights on the Middle East route. This consisted of 20 arrivals and 19 departures, including 38 regular flights and one charter flight.\"Following up on developments in flight operations on the Middle East route, we are reporting this based on route permit data issued by the relevant authorities and updated as of 10:00 AM LT,\" he said.","market":"fut","thumbnail":"https://statik.tempo.co/data/2025/12/23/id_1449385/1449385_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/12/23/id_1449385/1449385_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2090117/indonesias-soekarno-hatta-reschedules-39-middle-east-flights","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2090117/indonesias-soekarno-hatta-reschedules-39-middle-east-flights","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7508","BK4532","DXB","BK7067","DXB.AU","MED.AU","MED","BK7501","BK4183"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":100,"code":"91000000","status":"200"}]}}